Source:http://linkedlifedata.com/resource/pubmed/id/17448528
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-6-4
|
pubmed:abstractText |
The present study aimed to determine whether Nicotiflorin, a natural flavonoid extracted from coronal of Carthamus tinctorius, has a protective effect on cerebral multi-infarct dementia in rats. The multi-infarct dementia model rats were prepared by injecting man-made micro-thrombi into the right hemisphere. The administration groups were treated once daily with 30, 60 and 120 mg/kg Nicotiflorin (i.g.) from 5 days before ischemia operation to 3 days after the operation for biochemical examination, 10 days for Morris water maze study and morphological observations and 20 days for eight-arm radial maze task. 2,3,5-triphenyltetrazolium chloride (TTC) staining showed that infarct volume of each Nicotiflorin administration group was much smaller than that of vehicle-treated multi-infarct dementia group, and hematoxylin and eosin (HE) staining showed that histopathological abnormalities of each Nicotiflorin group were also much lighter than that of vehicle-treated multi-infarct dementia group. Each Nicotiflorin group showed much better spatial memory performance in Morris water maze tests and eight-arm radial maze task compared with the vehicle-treated multi-infarct dementia group, significantly attenuated the elevation of lactic acid and malondialdehyde (MDA) contents and the decrease in lactate dehydrogenase (LDH), Na(+)K(+)ATPase, Ca(2+)Mg(2+)ATPase and superoxide dismutase (SOD) activity in the brain tissue which was composed of striatum, cortex and hippocampus of the ischemia hemisphere at day 3 after ischemia operation. These results suggest that Nicotiflorin has protective effects on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0091-3057
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
86
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
741-8
|
pubmed:meshHeading |
pubmed-meshheading:17448528-Animals,
pubmed-meshheading:17448528-Brain,
pubmed-meshheading:17448528-Dementia, Multi-Infarct,
pubmed-meshheading:17448528-Disease Models, Animal,
pubmed-meshheading:17448528-Energy Metabolism,
pubmed-meshheading:17448528-Flavonoids,
pubmed-meshheading:17448528-Male,
pubmed-meshheading:17448528-Maze Learning,
pubmed-meshheading:17448528-Memory Disorders,
pubmed-meshheading:17448528-Neuroprotective Agents,
pubmed-meshheading:17448528-Oxidative Stress,
pubmed-meshheading:17448528-Phenols,
pubmed-meshheading:17448528-Rats,
pubmed-meshheading:17448528-Rats, Sprague-Dawley
|
pubmed:year |
2007
|
pubmed:articleTitle |
Protective effects of Nicotiflorin on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats.
|
pubmed:affiliation |
Department of Pharmacology, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|